Simrat Randhawa Biography and Net Worth

Insider of Dianthus Therapeutics

Dr. Randhawa brings over 20 years of clinical practice and pharmaceutical industry experience to Dianthus. He most recently served as Senior Vice President of Clinical and Medical Affairs at Aurinia Pharmaceuticals, an autoimmune-focused company, where he supported the clinical development of voclosporin and investor relations. Dr. Randhawa has held a number of senior commercial and medical leadership roles in the autoimmune and rare disease spaces within large pharma and biotech companies such as Novartis and Biomarin. Previously, he supported business development opportunities and integration needs in the health care sector while at McKinsey Consulting. Dr. Randhawa completed his M.D. at Drexel University and received his M.B.A. from Columbia University.

What is Simrat Randhawa's net worth?: The estimated net worth of Simrat Randhawa is at least $178.84 thousand as of November 13th, 2025. Randhawa owns 4,000 shares of Dianthus Therapeutics stock worth more than $178,840 as of December 4th. This net worth estimate does not reflect any other assets that Randhawa may own. Additionally, Randhawa receives an annual salary of $338,160.00 as Insider at Dianthus Therapeutics. Learn More about Simrat Randhawa's net worth.
How old is Simrat Randhawa?: Randhawa is currently 54 years old. There are 4 older executives and no younger executives at Dianthus Therapeutics. The oldest executive at Dianthus Therapeutics is Mr. Marino Garcia M.B.A., President, CEO, Secretary & Director, who is 58 years old. Learn More on Simrat Randhawa's age.
What is Simrat Randhawa's salary?: As the Insider of Dianthus Therapeutics, Inc., Randhawa earns $338,160.00 per year. The highest earning executive at Dianthus Therapeutics is Mr. Marino Garcia M.B.A., President, CEO, Secretary & Director, who commands a salary of $496,020.00 per year. Learn More on Simrat Randhawa's salary.
How do I contact Simrat Randhawa?: The corporate mailing address for Randhawa and other Dianthus Therapeutics executives is 203 Crescent Street, Building 17 Suite 102B, Waltham, MA 02453, United States, . Dianthus Therapeutics can also be reached via phone at 857-242-0170 and via email at [email protected]. Learn More on Simrat Randhawa's contact information.
Has Simrat Randhawa been buying or selling shares of Dianthus Therapeutics?: During the last ninety days, Simrat Randhawa has sold $7,379,575.01 of Dianthus Therapeutics stock. Most recently, Simrat Randhawa sold 109,031 shares of the business's stock in a transaction on Friday, November 14th. The shares were sold at an average price of $38.14, for a transaction totalling $4,158,442.34. Following the completion of the sale, the executive vice president now directly owns 4,000 shares of the company's stock, valued at $152,560. Learn More on Simrat Randhawa's trading history.
Who are Dianthus Therapeutics' active insiders?: Dianthus Therapeutics' insider roster includes Simrat Randhawa (Insider), and Ryan Savitz (CFO). Learn More on Dianthus Therapeutics' active insiders.
Are insiders buying or selling shares of Dianthus Therapeutics?: During the last twelve months, insiders at the sold shares 3 times. They sold a total of 216,538 shares worth more than $8,079,575.01. The most recent insider tranaction occured on November, 14th when EVP Simrat Randhawa sold 109,031 shares worth more than $4,158,442.34. Insiders at Dianthus Therapeutics own 8.2% of the company. Learn More about insider trades at Dianthus Therapeutics.
Information on this page was last updated on 11/14/2025.

Simrat Randhawa Insider Trading History at Dianthus Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/14/2025	Sell	109,031	$38.14	$4,158,442.34	4,000
11/13/2025	Sell	87,507	$36.81	$3,221,132.67	4,000
9/21/2023	Buy	2,000	$13.20	$26,400.00	2,000

Simrat Randhawa Buying and Selling Activity at Dianthus Therapeutics

Dianthus Therapeutics Company Overview

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. It is developing DNTH103, a monoclonal antibody, which is in Phase 2 clinical trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

Today's Range

Now: $44.71

$43.28

$45.46

50 Day Range

MA: $37.56

$32.92

$44.71

2 Week Range

Now: $44.71

$13.36

$45.46

Volume

512,788 shs

Average Volume

768,172 shs

Market Capitalization

$1.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.56

Simrat Randhawa Biography and Net Worth

What is Simrat Randhawa's net worth?

How old is Simrat Randhawa?

What is Simrat Randhawa's salary?

How do I contact Simrat Randhawa?

Has Simrat Randhawa been buying or selling shares of Dianthus Therapeutics?

Who are Dianthus Therapeutics' active insiders?

Are insiders buying or selling shares of Dianthus Therapeutics?